LONG-TERM OUTCOME FOLLOWING TOTAL PARATHYROIDECTOMY IN PATIENTS WITH END-STAGE RENAL-DISEASE

被引:2
|
作者
KAYE, M
ROSENTHALL, L
HILL, RO
TABAH, RJ
机构
[1] MONTREAL GEN HOSP,DEPT NUCL MED,MONTREAL H3G 1A4,QUEBEC,CANADA
[2] MONTREAL GEN HOSP,DEPT DIAGNOST RADIOL,MONTREAL H3G 1A4,QUEBEC,CANADA
[3] MONTREAL GEN HOSP,DEPT SURG,MONTREAL H3G 1A4,QUEBEC,CANADA
关键词
PARATHYROIDECTOMY; DIALYSIS; END-STAGE RENAL DISEASE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Long-term follow up (mean 3.8 years), following elective total parathyroidectomy in thirteen patients with end-stage renal disease is described. Nine patients are alive and all except two have measurable levels of intact parathyroid hormone (PTH). One patient is mildly hyperparathyroid with PTH levels of 143 pg/ml (normal 10-65 pg/ml). All patients did well as far as their bone and mineral metabolism were concerned and there were no fractures, bone pain or metastatic soft tissue calcification. Lumbar spine bone mineral density (BMD) increased above the baseline value and femoral neck bone density was significantly greater than a matched control group of non-parathyroidectomized dialysis patients (1.097 +/- 0.140 versus 0.811 +/- 0.148 g/cm2, Z-score 1.98 +/- 1.64 versus -0.79 +/- 1.07, p <0.001). Two of the nine patients have been transplanted, both have good allograft function and show increases in BMD. We believe that these findings justify the complete removal of all parathyroid tissue for selected patients with chronic renal failure where medical therapy has failed and aluminium bone disease has been excluded. They also raise the possibility that PTH is necessary for bone loss to occur.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 50 条
  • [1] Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease
    Hargrove, GM
    Pasieka, JL
    Hanley, DA
    Murphy, MB
    AMERICAN JOURNAL OF NEPHROLOGY, 1999, 19 (05) : 559 - 564
  • [3] Long-term outcomes of end-stage renal disease patients admitted to the ICU
    Sood, Manish M.
    Miller, Lisa
    Komenda, Paul
    Reslerova, Martina
    Bueti, Joe
    Santhianathan, Chris
    Roberts, Dan
    Mojica, Julie
    Rigatto, Claudio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (09) : 2965 - 2970
  • [4] Valve replacement surgery in patients with end-stage renal disease: Long-term results
    Gultekin, B
    Ozkan, S
    Uguz, E
    Atalay, H
    Akay, T
    Arslan, A
    Sezgin, A
    Ozdemir, N
    Tasdelen, A
    Aslamaci, S
    ARTIFICIAL ORGANS, 2005, 29 (12) : 972 - 975
  • [5] HYPERTENSIVE END-STAGE RENAL-DISEASE IN BLACKS - THE ROLE OF END-STAGE RENAL-DISEASE SURVEILLANCE
    MCCLELLAN, W
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (04) : 25 - 30
  • [6] Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients
    Kshirsagar, Abhijit, V
    Li, Xiaojuan
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 292 - 297
  • [7] Long-term outcomes of children with end-stage renal disease
    J. W. Groothoff
    Pediatric Nephrology, 2005, 20 : 849 - 853
  • [8] Long-term outcomes of children with end-stage renal disease
    Groothoff, JW
    PEDIATRIC NEPHROLOGY, 2005, 20 (07) : 849 - 853
  • [9] BIOAVAILABILITY OF LABETALOL IN PATIENTS WITH END-STAGE RENAL-DISEASE
    LUKE, DR
    AWNI, WM
    HALSTENSON, CE
    OPSAHL, JA
    MATZKE, GR
    THERAPEUTIC DRUG MONITORING, 1992, 14 (03) : 203 - 208
  • [10] CHANGING RISK FACTOR DEMOGRAPHICS IN END-STAGE RENAL-DISEASE PATIENTS ENTERING HEMODIALYSIS AND THE IMPACT ON LONG-TERM MORTALITY
    COLLINS, AJ
    HANSON, G
    UMEN, A
    KJELLSTRAND, C
    KESHAVIAH, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (05) : 422 - 432